Innate Pharma SA
(FRA:IDD)
€
2.035
0.02 (0.99%)
Market Cap: 166.75 Mil
Enterprise Value: 114.19 Mil
PE Ratio: 0
PB Ratio: 3.21
GF Score: 54/100 Innate Pharma SA (FRA:IDD) Transcripts
- Innate Pharma SA KOL Event TranscriptDec 12, 2023
- Q3 2023 Innate Pharma SA Corporate Sales Call TranscriptNov 14, 2023
- Half Year 2023 Innate Pharma SA Earnings Call TranscriptSep 14, 2023€2.81Earnings
- Q1 2023 Innate Pharma SA Earnings Call TranscriptMay 10, 2023€2.73 (-2.68%)Earnings
- Q4 2022 Innate Pharma SA Earnings Call TranscriptMar 23, 2023€2.86 (-0.07%)Earnings
- Q3 2022 Innate Pharma SA Earnings Call TranscriptNov 14, 2022€2.35 (+15.54%)Earnings
- Q2 2022 Innate Pharma SA Earnings Call TranscriptSep 15, 2022€2.55 (-1.77%)Earnings
- Q1 2022 Innate Pharma SA Earnings Call TranscriptMay 10, 2022€2.48 (-2.67%)Earnings
- Q4 2021 Innate Pharma SA Earnings Call TranscriptMar 24, 2022€3.1 (-0.64%)Earnings
- Q3 2021 Innate Pharma SA Corporate Sales Call TranscriptNov 16, 2021
- Q2 2021 Innate Pharma SA Earnings Call TranscriptSep 15, 2021€4.63 (-5.55%)Earnings
- Innate Pharma SA To Discuss Virtual Investor Event-Call TranscriptJun 23, 2021
- Q1 2021 Innate Pharma SA Earnings Call TranscriptMay 11, 2021€3.16 (-3.60%)Earnings
- Q4 2020 Innate Pharma SA Earnings Call TranscriptMar 18, 2021€3.86 (-3.16%)Earnings
- 1